Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
lenvatinib
×
30 days
×
Clear all
Filters
3
NCT04938817
2026-03-19
KEYNOTE-B98
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
110 enrolled